Thank you to our speakers, sponsors, and delegates who joined us in Boston, MA for the summit! If you are interested in the 2024 event, please get in touch at 

Integrating Advanced 3D Models to Empower Drug Discovery & Development

Following the excitement behind President Biden signing the FDA modernization Act 2.0 in December 2022, Hesperos and Sanofi successfully getting IND approval from organ-on-chip data for a Phase 2 clinical trial, and NIH bioprinting eye tissue to develop in vitro models of AMD, the 8th Annual 3D Tissue Models Summit returned to Boston in May 2023 to reunite the community of drug discovery and development experts. This was the definitive meeting for drug developers to explore and integrate complex 3D models featuring 26+ real-life case studies across 2 dedicated tracks and their lessons learned.

With biopharma including Amgen showing more interest towards 3D models, there has never been a greater need for more clarity and strategies to implement 3D models into your company’s drug discovery and development workflows.

What’s Exciting in the World of 3D Tissue Models?

3dtm small logo
3dtm small logo
3dtm small logo

3D models have gone to space again: In March, 3D models from the BRAINS project were sent to the ISS to study overall cell structure changes within space conditions – Hear some insights on this from Kristin Fabre, Deputy Chief Scientist at the Human Research Program, NASA.  Check out her talk here.

More tissue and disease models are being developed: The Harvard Wyss Institute and Gameto are developing ovarian organoids for reproductive health, while the Hubrecht Institute is implementing NAFLD organoids for target identification.

Developing drugs becomes faster by leveraging the immune system: Amgen is implementing 3D bioprinted tonsil tissue to predict drug efficacy by studying the tissue immune responses

2023 Expert Speakers Included:

Adriana Martinez Ledo

Principal Scientist


Anirban Chatterjee

Director, Trans. Research Solutions


Beth Hoffman

Founder & Chief Executive Officer

Origami Therapeutics

Leah Norona

Senior Scientist, Investigative Toxicology


Magdalena Kasendra

Director of Research and Development

Cincinnati Children’s Hospital

Matthias von Herrath

Vice President and Senior Medical Officer, Global Chief Medical Office

Novo Nordisk

Remi Villenave

Lab Head


Richard Hanna

Associate Director Bioscience Immunology


Roger Kamm



Tuyen Nguyen

Principal Scientist

Alnylam Pharmaceuticals

Why Did Experts Attend?

“This was highly educational and exhilarating, and I would recommend it to anyone seeking both practical information and broad perspective”

- BioAnalytics Product Management, Sartorius


“Brilliant mix of new data/knowledge taken from a great group of experts who are so obviously excited about the future of Advanced Cell Systems" -  Head of Department, Merck

“I learned a lot for the 3D model regarding its current status, application potentials and challenges”

- Scientific Leader, GSK

W4c (8)

"Nice to see people again at these in-person events - the hosts were very welcoming and everybody seemed pleased to be there" - Director, Advanced Solutions, Corning Life Sciences

What Was Unique About the 8th 3D Tissue Models Summit?

20326 - 3D Tissue Models Summit - Favicon
20326 - 3D Tissue Models Summit - Favicon
20326 - 3D Tissue Models Summit - Favicon

The only industry-focussed 3D tissue models summit to share ideas: delve into real-world applications for drug discovery and development with an industrial and regulatory environment in mind – not only for educational purpose but also form pre-competitive collaboration!

Discover the latest technologies: We provide a unique platform for drug developers to exchange challenges, inspire solutions whilst assessing the latest technologies

Multiple networking opportunities: your chance to shake hands and meet fellow colleagues and new connections face-to-face in an intimate setting

Previous Attendees Include:
2023 Confirmed Partners Included:
Other Events in the Series: